How Essence Healthcare Uses ŌURA to Proactively Connect Members to Physicians for Sleep Apnea Risk Evaluation

Why It Matters

Early detection of obstructive sleep apnea can lower costly hospitalizations and cardiovascular events, directly impacting Medicare Advantage cost structures and quality metrics.

Key Takeaways

• 65% of eligible Essence members share Oura data for care programs
• BDI ≥15 events/hour triggers AI-driven outreach and STOP‑BANG screening
• Pre‑call text builds trust before Tom’s AI phone call
• Positive screens are routed to primary care or care‑management team
• Early OSA identification could cut average $19,500 annual Medicare costs

Pulse Analysis

Obstructive sleep apnea (OSA) remains a silent epidemic, affecting roughly 30 million U.S. adults, with 80% undiagnosed. For Medicare Advantage (MA) plans, undetected OSA translates into higher cardiovascular events, emergency visits, and inflated per‑member costs—averaging about $19,500 annually per untreated senior. Regulatory pressures, star‑rating incentives, and the need for proactive chronic‑disease management have pushed MA carriers to seek data‑driven solutions that identify risk before symptoms surface. Wearables, especially the Oura Ring, provide a unique, continuous stream of sleep‑related metrics that can serve as early warning signals.

Essence Healthcare’s program leverages that data by integrating Oura’s Breathing Disturbance Index (BDI) with Lumeris’s Tom AI assistant. Members who consent (about 65% of the eligible cohort) share their nightly BDI scores via a secure API. When the average BDI exceeds 15 events per hour, Tom initiates a trust‑building workflow: a pre‑call text identifies the AI, followed by a phone or text‑based STOP‑BANG questionnaire. The process respects member autonomy—participants can pause or decline—while ensuring that every positive screen is escalated to a primary care physician or, if none is on file, to a dedicated care‑management team. This closed‑loop design keeps diagnosis firmly in clinical hands and mitigates the risk of over‑diagnosis.

The broader implication for the health‑insurance industry is clear. A single, high‑yield use case—OSA screening—demonstrates how wearable data, AI outreach, and physician oversight can be combined into a scalable, cost‑effective care pathway. As MA plans grapple with aging populations and rising chronic‑disease burdens, the Essence‑Oura model offers a blueprint for expanding into cardiometabolic risk, fall prevention, and activity‑related conditions. By converting passive wellness signals into actionable clinical interventions, insurers can improve outcomes, reduce expenditures, and differentiate their offerings in an increasingly competitive market.